Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Pneumonitis
ADR ID BADD_A03482
ADR Hierarchy
22      Respiratory, thoracic and mediastinal disorders
22.01      Lower respiratory tract disorders (excl obstruction and infection)
22.01.01      Lower respiratory tract inflammatory and immunologic conditions
22.01.01.006      Pneumonitis
Description A disorder characterized by inflammation focally or diffusely affecting the lung parenchyma. [CTCAE] Infection of the lung often accompanied by inflammation. | Inflammation of any part, segment or lobe, of the lung parenchyma. [MeSH]
MedDRA Code 10035742
MeSH ID D011014
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Pneumonitis | Pneumonitis NOS | Pulmonitis | Lung inflammation | Chronic pneumonitis | Obstructive pneumonitis | Noninfectious pneumonitis | Pneumonia | Pneumonias | Lobar Pneumonia | Lobar Pneumonias | Pneumonias, Lobar | Pneumonia, Lobar | Experimental Lung Inflammation | Experimental Lung Inflammations | Inflammation, Experimental Lung | Lung Inflammation, Experimental | Lung Inflammations, Experimental | Pneumonitides | Pulmonary Inflammation | Inflammation, Pulmonary | Inflammations, Pulmonary | Pulmonary Inflammations | Lung Inflammation | Inflammation, Lung | Inflammations, Lung | Lung Inflammations
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01081Hydralazine0.000170%
BADD_D01083Hydrochlorothiazide--
BADD_D01110Hydroxyurea0.000280%
BADD_D01119Ibrutinib0.003033%
BADD_D01130Idelalisib0.003078%
BADD_D01133Ifosfamide--
BADD_D01136Imatinib0.001007%
BADD_D01149Indapamide--
BADD_D01166Interferon alfa-2a--
BADD_D01167Interferon alfa-2b--
BADD_D01184Iothalamic acid--
BADD_D01190Ipilimumab--
BADD_D01195Irinotecan0.000246%
BADD_D01204Isoniazid0.008339%
BADD_D01222Ixabepilone--
BADD_D01248Lapatinib0.000112%
BADD_D01252Leflunomide0.002656%
BADD_D01253Lenalidomide--
BADD_D01254Lenvatinib0.000694%
BADD_D01257Letrozole0.000790%
BADD_D01275Levofloxacin0.000430%
BADD_D01285Levothyroxine--
BADD_D01336Macitentan0.001564%
BADD_D01370Mefloquine hydrochloride--
BADD_D01378Memantine0.000242%
BADD_D01397Mesalamine0.000366%
BADD_D01418Methotrexate0.007357%
BADD_D01423Methyclothiazide--
BADD_D01470Minocycline0.000236%
BADD_D01491Mometasone furoate0.003368%
The 3th Page    First    Pre   3 4 5 6    Next   Last    Total 6 Pages